Source link : https://www.newshealth.biz/health-news/oral-drug-safe-effective-in-kids-with-achondroplasia/
The oral FGFR1-3 selective tyrosine kinase inhibitor infigratinib was found to be safe and effective at the highest studied dose among children with achondroplasia in a phase II dose-finding study. During treatment, all 72 participants had at least one adverse event, though most were mild (54%) or moderate (39%) in severity, and none resulted in […]
Author : News Health
Publish date : 2024-11-18 10:00:00
Copyright for syndicated content belongs to the linked Source.